Methods for causality assessment of idiosyncratic drug‐induced liver injury
Liver International · 2025-03 · 45 (3)
DOI: 10.1111/liv.16083 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Liver International, online erschienen am 21.08.2024. Verfasst von Miren García-Cortés und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Instituto de Salud Carlos III, Agencia Estatal de Investigación, Ministerio de Ciencia, Innovación y Universidades.
Abstract (Originalsprache)
The diagnosis of idiosyncratic drug‐induced liver injury (DILI) is a challenging task due to the lack of specific features or definitive diagnostic tools. A minimum of clinical and pharmacological information is required, together with laboratory and imaging tests to exclude other causes of liver injury. Several standardized methods have been developed to support clinical judgement and establish causality assessment, the most widely used being the Roussel Uclaf Causality Assessment Method—RUCAM—and structured Expert Opinion. More recently, an evidence‐based, revised RUCAM, Electronic Causality Assessment Method—RECAM—has been developed and, although still a work in progress, may replace RUCAM scoring in the future. International collaborative networks and ongoing research efforts are key to advancing biomarker qualification and validation and developing new in vitro patient‐based methods that will help improve DILI diagnosis and move towards a personalized medicine approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicios de Aparato Digestivo y Farmacología Clínica, Hospital Universitario Virgen de la Victoria, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA, Plataforma BIONAND, Universidad de…
- Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
- Plataforma del ISCIII para la Investigación Clínica, UICEC-IBIMA, SCReN, Madrid, Spain.
ORCID-Profile: Miren García-Cortés, Gonzalo Matilla-Cabello, M Isabel Lucena
Förderung
- Instituto de Salud Carlos III
- Agencia Estatal de Investigación
- Ministerio de Ciencia, Innovación y Universidades
Zitieren
APA
García-Cortés, M., Matilla-Cabello, G., & Lucena, M. I. (2025). Methods for causality assessment of idiosyncratic drug‐induced liver injury. Liver International, 45(3). https://doi.org/10.1111/liv.16083
Vancouver
García-Cortés M, Matilla-Cabello G, Lucena MI. Methods for causality assessment of idiosyncratic drug‐induced liver injury. Liver International. 2025;45(3). doi:10.1111/liv.16083
BibTeX
@article{GarcaCorts2025,
author = {García-Cortés, Miren and Matilla-Cabello, Gonzalo and Lucena, M Isabel},
title = {Methods for causality assessment of idiosyncratic drug‐induced liver injury},
journal = {Liver International},
year = {2025},
volume = {45},
number = {3},
doi = {10.1111/liv.16083}
}
EUVIMED